OncoGenex Pharmaceuticals, Inc. (OGXI) Tops Q3 EPS by 9c

Article Related Press Releases (1) Stock Quotes (1) Comments (0)

OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) reported Q3 EPS of ($0.40), $0.09 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $6.57 million versus the consensus estimate of $4.52 million.

For earnings history and earnings-related data on OncoGenex Pharmaceuticals, Inc. (OGXI) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
• Semtech Corp (SMTC) Reports In-Line Q1 EPS, Offers Q2 Guidance
• Booz Allen Hamilton (BAH) Tops Q4 EPS by 3c; Guides In-Line FY14 EPS

Create E-mail Alert Related Categories

Earnings

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?